Table 2.
Perioperative data and surgical outcomes.
| Control group (n = 30) | GnRH agonists group (n = 31) | P value | |
|---|---|---|---|
| Size of leiomyoma at the time of surgery | |||
| Maximum diameter (cm) | 4.33 ± 0.8 | 3.82 ± 0.6 | .004 |
| Volume (cm3) | 33.22 ± 24.7 | 23.19 ± 10.4 | .042 |
| Weight (g) | 33.20 ± 25.0 | 22.32 ± 11.9 | .033 |
| Type of anesthesia | .202 | ||
| Spinal | 14 (46.7%) | 20 (64.5%) | |
| General | 16 (53.3%) | 11 (35.5%) | |
| Surgical apparatus | 1.000 | ||
| Bipolar | 10 (33.3%) | 11 (35.5%) | |
| Monopolar | 20 (66.7%) | 20 (64.5%%) | |
| Type of media | 1.000 | ||
| Urosol | 20 (66.7%) | 20 (64.5%) | |
| Normal saline | 10 (33.3%) | 11 (35.5%) | |
| Operation time (min) | 43.97 ± 12.9 | 37.71 ± 10.2 | .040 |
| Uterine-distending media (mL) | |||
| Input | 9373.33 ± 5657.8 | 6800.00 ± 3552.4 | .037 |
| Output | 8723.33 ± 5453.9 | 6432.26 ± 3266.1 | .050 |
| Imbalance (input – output) | 650.00 ± 318.1 | 367.74 ± 430.0 | .005 |
| Estimated blood loss (mL) | 27.03 ± 42.1 | 25.84 ± 42.0 | .914 |
| Perioperative WBC count | |||
| Preoperative WBC count (/µL) | 6094.67 ± 2172.4 | 5712.90 ± 1424.0 | .419 |
| Postoperative WBC count (/µL) | 6449.33 ± 1744.9 | 6500.97 ± 1792.56 | .910 |
| Perioperative Hb level | |||
| Preoperative Hb level (g/dL) | 11.01 ± 1.5 | 10.15 ± 1.2 | .018 |
| Postoperative Hb level (g/dL) | 10.83 ± 1.5 | 10.07 ± 1.3 | .039 |
| Hemoglobin decrease (g/dL) | 0.18 ± 1.2 | 0.09 ± 0.8 | .682 |
| Duration of hospital stay (d) | 3.50 ± 1.1 | 3.13 ± 0.3 | .080 |
| Uterine balloon tamponade | 1 (3.3%) | 3 (9.7%) | .612 |
| Remnant leiomyoma | 1 (3.3%) | 3 (9.7%) | .612 |
| Recurrence | 1 (3.3%) | 2 (6.5%) | 1.00 |
| Pregnancy | 2 (6.7%) | 5 (16.1%) | .425 |